Jump to navigation
The latest clinical and political news for Australian Rheumatologists
And the industry may underestimate the problem.
There’s a threat of toxic retinopathy, researchers warn
Staying on the drug can benefit patients with axial spondyloarthritis
Study from SA shows high prevalence and poor adherence.
Less time than you may expect...
They seek improvements in sleep, pain and emotional wellbeing.
But one class does not seem to be effective.
But after five years, risks are nearly normal.
Increased frequency of GP visits is something to be alert to.
Pain decreases proportionately.
The effect may be due to more than decreasing inflammation.
But SSRIs may help.
Patient and GP delays matter most.
The elderly often skimp on protein, an expert says.
A mental health assessment is recommended.
Largest study to date includes tens of thousands of cases.
Professor Buchbinder throws down the gauntlet
Some patients go undiagnosed for years.
ARA2018 delegates told few patients referred for exercise therapy.
International expert speaks to ARA2018 delegates
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.